These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 16786631)
1. [Research of modulation of CD95-mediated apoptosis in lymphoblastic MP-1 and BJAB cells infected by adenovirus and Epstein-Barr virus]. Nesterova NV; Diachenko NS; Zahorodnia SD; Nosach LM; Povnytsia OIu; Baranova HV; Zhovnovata VL Mikrobiol Z; 2006; 68(2):75-83. PubMed ID: 16786631 [TBL] [Abstract][Full Text] [Related]
2. Study of adenovirus reproduction in different lymphoblastoid cell lines. Biliavska LO; Povnitsa OY; Nesterova NV; Zagorodnya SD; Bobko TM; Golovan AV; Voychuk SI Mikrobiol Z; 2014; 76(6):34-40. PubMed ID: 25639041 [TBL] [Abstract][Full Text] [Related]
3. Expression of target antigen for Epstein-Barr virus-specific cytotoxic T cells on BJAB cells freshly infected with EBV. Sugamura K; Tanaka Y; Hinuma Y Microbiol Immunol; 1982; 26(7):575-83. PubMed ID: 6290853 [TBL] [Abstract][Full Text] [Related]
4. [INFLUENCE OF DOXORUBICIN AND ETOPOSIDE ON THE CD 95 MEDIATED APOPTOSIS IN EBV INFECTED LYMPHOMA CELLS BL-41 AND DG-75]. Zagorodnya SD; Baranova GV; Nesterova NV Mikrobiol Z; 2015; 77(4):69-74. PubMed ID: 26422926 [TBL] [Abstract][Full Text] [Related]
5. Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains. Kanda T; Furuse Y; Oshitani H; Kiyono T J Virol; 2016 May; 90(9):4383-93. PubMed ID: 26889033 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation. Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694 [TBL] [Abstract][Full Text] [Related]
7. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo. Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618 [TBL] [Abstract][Full Text] [Related]
8. A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy. Chia MC; Shi W; Li JH; Sanchez O; Strathdee CA; Huang D; Busson P; Klamut HJ; Liu FF Mol Ther; 2004 Jun; 9(6):804-17. PubMed ID: 15194047 [TBL] [Abstract][Full Text] [Related]
9. Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation. Sbih-Lammali F; Clausse B; Ardila-Osorio H; Guerry R; Talbot M; Havouis S; Ferradini L; Bosq J; Tursz T; Busson P Cancer Res; 1999 Feb; 59(4):924-30. PubMed ID: 10029086 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression. Kim M; Sgagias M; Deng X; Jung YJ; Rikiyama T; Lee K; Ouellette M; Cowan K Biochem Biophys Res Commun; 2004 Jul; 320(1):138-44. PubMed ID: 15207713 [TBL] [Abstract][Full Text] [Related]
11. [The viral genome status studied under the conditions of a mixed infection in lymphoblastoid cells by adenovirus and the Epstein-Barr virus]. Nosach LN; Diachenko NS; Povnitsa OIu; Smirnova IA; Kishinskaia EG; Butenko ZA; Panasenko GV Tsitol Genet; 1998; 32(4):82-8. PubMed ID: 9813890 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay. Nishiwaki M; Fujimuro M; Teishikata Y; Inoue H; Sasajima H; Nakaso K; Nakashima K; Sadanari H; Yamamoto T; Fujiwara Y; Ogawa N; Yokosawa H J Med Virol; 2006 Dec; 78(12):1635-42. PubMed ID: 17063511 [TBL] [Abstract][Full Text] [Related]
13. The activation of lytic replication of Epstein-Barr virus by baculovirus-mediated gene transduction. Wang L; Shan L; Yin J; Zhao M; Su D; Zhong J Arch Virol; 2006 Oct; 151(10):2047-53. PubMed ID: 16673043 [TBL] [Abstract][Full Text] [Related]
14. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005 [TBL] [Abstract][Full Text] [Related]
15. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection. Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program. De Leo A; Arena G; Stecca C; Raciti M; Mattia E Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773 [TBL] [Abstract][Full Text] [Related]
17. Direct demonstration of persistent Epstein-Barr virus gene expression in peripheral blood of infected common marmosets and analysis of virus-infected tissues in vivo. Farrell PJ; Hollyoake M; Niedobitek G; Agathanggelou A; Morgan A; Wedderburn N J Gen Virol; 1997 Jun; 78 ( Pt 6)():1417-24. PubMed ID: 9191939 [TBL] [Abstract][Full Text] [Related]